How have the results of the phase III RTOG 0631 trial impacted your use of spine SBRT?

NRG/RTOG and the investigators are commendable for completing this important trial and reporting the outcomes. The possible reasons for the negative results of the SBRT arm were discussed in the plenary session at ASTRO 2019 and in the Discussion section of the JAMA Oncol paper by the authors. This ...

To answer the question directly, yes, I do still offer SBRT for vertebral mets. It is important to note, the RTOG 0631 recently published was for denovo spine mets. It is an important dataset esp given the question at hand. However, my approach to spine SRS has been with the following criteria:

• Prio...